Enzo Biochem, Inc. (NYSE: ENZ) today reported strong operating results for the fiscal first quarter ended October 31, 2014.
•Total revenues increased 3% year over year; up 6%, excluding royalties and licensing fees. •Gross margins at Enzo Clinical Labs and Enzo Life Sciences increased 10% and 13%, respectively, year over year.
Help employers find you! Check out all the jobs and post your resume.
•Total revenues increased 3% year over year; up 6%, excluding royalties and licensing fees. •Gross margins at Enzo Clinical Labs and Enzo Life Sciences increased 10% and 13%, respectively, year over year.
Help employers find you! Check out all the jobs and post your resume.
